vs
Apellis Pharmaceuticals, Inc.（APLS）与Westrock Coffee Co（WEST）财务数据对比。点击上方公司名可切换其他公司
Westrock Coffee Co的季度营收约是Apellis Pharmaceuticals, Inc.的1.7倍（$339.5M vs $199.9M），Westrock Coffee Co净利率更高（-6.6% vs -29.5%，领先22.8%），Westrock Coffee Co同比增速更快（48.3% vs -5.9%），Westrock Coffee Co自由现金流更多（$27.8M vs $-14.3M），过去两年Westrock Coffee Co的营收复合增速更高（32.8% vs 7.7%）
Apellis Pharmaceuticals是一家临床阶段生物制药企业，专注于开发调节补体系统的靶向疗法，适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病，核心市场为美国及欧盟地区。
Westrock Coffee Co是一家全球化综合咖啡及饮品解决方案供应商，业务覆盖咖啡、茶与功能性饮品的采购、烘焙、生产及分销，为北美及全球其他区域的零售、餐饮和商业客户提供定制化产品及配套服务。
APLS vs WEST — 直观对比
营收规模更大
WEST
是对方的1.7倍
$199.9M
营收增速更快
WEST
高出54.2%
-5.9%
净利率更高
WEST
高出22.8%
-29.5%
自由现金流更多
WEST
多$42.1M
$-14.3M
两年增速更快
WEST
近两年复合增速
7.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $199.9M | $339.5M |
| 净利润 | $-59.0M | $-22.6M |
| 毛利率 | — | 11.5% |
| 营业利润率 | -25.6% | -2.6% |
| 净利率 | -29.5% | -6.6% |
| 营收同比 | -5.9% | 48.3% |
| 净利润同比 | -62.2% | 8.3% |
| 每股收益（稀释后） | $-0.40 | $-0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APLSWEST
| Q4 25 | $199.9M | $339.5M | ||
| Q3 25 | $458.6M | $354.8M | ||
| Q2 25 | $178.5M | $280.9M | ||
| Q1 25 | $166.8M | $213.8M | ||
| Q4 24 | $212.5M | $229.0M | ||
| Q3 24 | $196.8M | $220.9M | ||
| Q2 24 | $199.7M | $208.4M | ||
| Q1 24 | $172.3M | $192.5M |
净利润APLSWEST
| Q4 25 | $-59.0M | $-22.6M | ||
| Q3 25 | $215.7M | $-19.1M | ||
| Q2 25 | $-42.2M | $-21.6M | ||
| Q1 25 | $-92.2M | $-27.2M | ||
| Q4 24 | $-36.4M | $-24.6M | ||
| Q3 24 | $-57.4M | $-14.3M | ||
| Q2 24 | $-37.7M | $-17.8M | ||
| Q1 24 | $-66.4M | $-23.7M |
毛利率APLSWEST
| Q4 25 | — | 11.5% | ||
| Q3 25 | — | 11.7% | ||
| Q2 25 | — | 14.7% | ||
| Q1 25 | — | 13.6% | ||
| Q4 24 | — | 16.6% | ||
| Q3 24 | — | 16.8% | ||
| Q2 24 | — | 19.9% | ||
| Q1 24 | — | 19.4% |
营业利润率APLSWEST
| Q4 25 | -25.6% | -2.6% | ||
| Q3 25 | 48.7% | -2.4% | ||
| Q2 25 | -18.6% | -5.3% | ||
| Q1 25 | -50.0% | -6.1% | ||
| Q4 24 | -12.3% | -4.3% | ||
| Q3 24 | -24.0% | -5.8% | ||
| Q2 24 | -14.7% | -7.9% | ||
| Q1 24 | -36.0% | -5.3% |
净利率APLSWEST
| Q4 25 | -29.5% | -6.6% | ||
| Q3 25 | 47.0% | -5.4% | ||
| Q2 25 | -23.6% | -7.7% | ||
| Q1 25 | -55.3% | -12.7% | ||
| Q4 24 | -17.1% | -10.7% | ||
| Q3 24 | -29.2% | -6.5% | ||
| Q2 24 | -18.9% | -8.5% | ||
| Q1 24 | -38.5% | -12.3% |
每股收益（稀释后）APLSWEST
| Q4 25 | $-0.40 | $-0.22 | ||
| Q3 25 | $1.67 | $-0.20 | ||
| Q2 25 | $-0.33 | $-0.23 | ||
| Q1 25 | $-0.74 | $-0.29 | ||
| Q4 24 | $-0.30 | $-0.26 | ||
| Q3 24 | $-0.46 | $-0.16 | ||
| Q2 24 | $-0.30 | $-0.20 | ||
| Q1 24 | $-0.54 | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $466.2M | $49.9M |
| 总债务越低越好 | — | $444.1M |
| 股东权益账面价值 | $370.1M | $-1.9M |
| 总资产 | $1.1B | $1.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资APLSWEST
| Q4 25 | $466.2M | $49.9M | ||
| Q3 25 | $479.2M | $34.0M | ||
| Q2 25 | $370.0M | $44.0M | ||
| Q1 25 | $358.4M | $33.1M | ||
| Q4 24 | $411.3M | $26.2M | ||
| Q3 24 | $396.9M | $22.4M | ||
| Q2 24 | $360.1M | $24.3M | ||
| Q1 24 | $325.9M | $12.6M |
总债务APLSWEST
| Q4 25 | — | $444.1M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $393.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $93.1M | — |
股东权益APLSWEST
| Q4 25 | $370.1M | $-1.9M | ||
| Q3 25 | $401.2M | $11.4M | ||
| Q2 25 | $156.3M | $18.2M | ||
| Q1 25 | $164.2M | $71.4M | ||
| Q4 24 | $228.5M | $97.5M | ||
| Q3 24 | $237.1M | $110.3M | ||
| Q2 24 | $264.3M | $81.5M | ||
| Q1 24 | $266.7M | $91.7M |
总资产APLSWEST
| Q4 25 | $1.1B | $1.2B | ||
| Q3 25 | $1.1B | $1.2B | ||
| Q2 25 | $821.4M | $1.2B | ||
| Q1 25 | $807.3M | $1.1B | ||
| Q4 24 | $885.1M | $1.1B | ||
| Q3 24 | $901.9M | $1.1B | ||
| Q2 24 | $904.5M | $1.1B | ||
| Q1 24 | $831.9M | $983.3M |
负债/权益比APLSWEST
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 4.03× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.35× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.2M | $36.7M |
| 自由现金流经营现金流 - 资本支出 | $-14.3M | $27.8M |
| 自由现金流率自由现金流/营收 | -7.1% | 8.2% |
| 资本支出强度资本支出/营收 | 0.1% | 2.6% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $45.0M | $-107.8M |
8季度趋势，按日历期对齐
经营现金流APLSWEST
| Q4 25 | $-14.2M | $36.7M | ||
| Q3 25 | $108.5M | $-26.6M | ||
| Q2 25 | $4.4M | $-7.0M | ||
| Q1 25 | $-53.4M | $-22.1M | ||
| Q4 24 | $19.4M | $2.8M | ||
| Q3 24 | $34.1M | $-332.0K | ||
| Q2 24 | $-8.3M | $-23.7M | ||
| Q1 24 | $-133.0M | $8.0M |
自由现金流APLSWEST
| Q4 25 | $-14.3M | $27.8M | ||
| Q3 25 | $108.3M | $-44.7M | ||
| Q2 25 | $4.4M | $-27.5M | ||
| Q1 25 | $-53.4M | $-63.4M | ||
| Q4 24 | $19.3M | $-15.4M | ||
| Q3 24 | — | $-36.7M | ||
| Q2 24 | $-8.4M | $-59.9M | ||
| Q1 24 | $-133.3M | $-60.9M |
自由现金流率APLSWEST
| Q4 25 | -7.1% | 8.2% | ||
| Q3 25 | 23.6% | -12.6% | ||
| Q2 25 | 2.5% | -9.8% | ||
| Q1 25 | -32.0% | -29.7% | ||
| Q4 24 | 9.1% | -6.7% | ||
| Q3 24 | — | -16.6% | ||
| Q2 24 | -4.2% | -28.7% | ||
| Q1 24 | -77.3% | -31.7% |
资本支出强度APLSWEST
| Q4 25 | 0.1% | 2.6% | ||
| Q3 25 | 0.0% | 5.1% | ||
| Q2 25 | 0.0% | 7.3% | ||
| Q1 25 | 0.0% | 19.3% | ||
| Q4 24 | 0.0% | 7.9% | ||
| Q3 24 | 0.0% | 16.5% | ||
| Q2 24 | 0.0% | 17.4% | ||
| Q1 24 | 0.2% | 35.8% |
现金转化率APLSWEST
| Q4 25 | — | — | ||
| Q3 25 | 0.50× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
WEST
| Coffee And Tea | $202.6M | 60% |
| Flavors Extracts And Ingredients | $69.6M | 21% |
| Sustainable Sourcing And Traceability Segments | $66.9M | 20% |
